Abstract
PRESIDENT GEORGE W. BUSH has announced an ambitious $7.1 billion plan to prepare U.S. for a possible influenza pandemic. The strategy he outlined on Nov. 1 at NIH in Bethesda, Md., includes $1 billion to stockpile antiviral drugs and more than $1 billion for vaccine development. The cornerstone of Bush strategy is $2.8 billion for accelerating development of cell-culture technology for vaccine production. Current techniques using eggs involve a six- to eight-month process before a vaccine is available. Bush is also asking Congress to strengthen liability protections for vaccine makers. The pharmaceutical industry appears to be pleased with Bush's plan, but some public health groups complain that it lacks key elements. Today's efforts are an excellent and comprehensive first step to prepare for a flu pandemic, says Billy Tauzin, president of Pharmaceutical Research & Manufacturers of America. A spokesperson for advocacy group Trust for America's Health, however, says that the ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.